Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Toscani

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Population Health Management|November 2, 2012
Risk evaluation mitigation strategies: the evolution of risk management policyKristen Hollingsworth, Michael Toscani
Managed Care (Langhorne, Pa.)|October 14, 2011
Meeting the challenges and burdens associated with hereditary angioedemaMichael Toscani, Marc Riedl
Journal of Pharmacy Practice|August 1, 2018
Telepharmacy: A New Paradigm for Our ProfessionTin Le, Michael Toscani, John Colaizzi
Biotechnology Healthcare|April 6, 2012
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2David B Nash, Michael Toscani, F Randy Vogenberg
Biotechnology Healthcare|April 6, 2012
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholdersDavid B Nash, Michael Toscani, F Randy Vogenberg
Therapeutic Innovation & Regulatory Science|September 18, 2018
Analysis of Social Media Interactions Between Pharmaceutical Companies and Consumers: The Power of the "Like"William Jackson, Boas Park, Michael Toscani, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion DiagnosticsMarilyn Tsourounis, Jeffrey Stuart, William Pignato, et al.
Journal of Pharmacy Practice|January 20, 2026
Evaluation of Readability of Educational Materials for Coronary Artery Disease and the Impact of Health Literacy on Medication Adherence and Health OutcomesKatelyn Gillies, Alexandra Bell, Caitlin McCarthy, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Challenges in the Development of Drug/Device and Biologic/Device Combination Products in the United States and European Union: A Summary From the 2013 DIA Meeting on Combination ProductsMarilyn Tsourounis, Jeffrey Stuart, MaryAnn Smith, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 3, 2020
Age demographics of subjects enrolled in interventional phase 3 multiple myeloma clinical trialsAbhilasha Borad, Hamnah Saeed, Michael Toscani, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Population Health Management|November 2, 2012
Risk evaluation mitigation strategies: the evolution of risk management policyKristen Hollingsworth, Michael Toscani
Managed Care (Langhorne, Pa.)|October 14, 2011
Meeting the challenges and burdens associated with hereditary angioedemaMichael Toscani, Marc Riedl
Journal of Pharmacy Practice|August 1, 2018
Telepharmacy: A New Paradigm for Our ProfessionTin Le, Michael Toscani, John Colaizzi
Biotechnology Healthcare|April 6, 2012
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2David B Nash, Michael Toscani, F Randy Vogenberg
Biotechnology Healthcare|April 6, 2012
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholdersDavid B Nash, Michael Toscani, F Randy Vogenberg
Therapeutic Innovation & Regulatory Science|September 18, 2018
Analysis of Social Media Interactions Between Pharmaceutical Companies and Consumers: The Power of the "Like"William Jackson, Boas Park, Michael Toscani, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion DiagnosticsMarilyn Tsourounis, Jeffrey Stuart, William Pignato, et al.
Journal of Pharmacy Practice|January 20, 2026
Evaluation of Readability of Educational Materials for Coronary Artery Disease and the Impact of Health Literacy on Medication Adherence and Health OutcomesKatelyn Gillies, Alexandra Bell, Caitlin McCarthy, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Challenges in the Development of Drug/Device and Biologic/Device Combination Products in the United States and European Union: A Summary From the 2013 DIA Meeting on Combination ProductsMarilyn Tsourounis, Jeffrey Stuart, MaryAnn Smith, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 3, 2020
Age demographics of subjects enrolled in interventional phase 3 multiple myeloma clinical trialsAbhilasha Borad, Hamnah Saeed, Michael Toscani, et al.
Pageof 3